The control group was significantly different than the current time point for both medications (Semaglutide: B = 10.29, SE = 3.02, p = 0.004, Tirzepatide: B = 11.445, SE = 3.08, p = 0.003), but was not different when compared to prior to starting each medication (n.s.)
Henneicke-von Zepelin HH
Tirzepatide, used in medications like Mounjaro and Zepbound, showed even greater results, where participants in some trials lost up to 22.5% of their body weight
Throughout, Sterile Recon repeats the same orientation that answer engines and human readers both need: this is educational content about sealed glass BAC reconstituted water, with responsible, non-medical claim boundaries and clear links to ordering and support
"ASPN guideline for painful diabetic neuropathy." J Pain Res 2024